Phosphoric Acid

Phosphoric Acid

SCHEMBL114277

O.O.O.O=P([O-])([O-])O.[K+].[K+]

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.73
LMNA P02545 2/20 0.40
KDM4E B2RXH2 2/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
CA2 P00918 1/20 0.39
MMP2 P08253 1/20 0.33
THRB P10828 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
FDPS P14324 1/20 0.33
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CA1 P00915 2/20 0.30
CA4 P22748 2/20 0.30
CA5A P35218 2/20 0.30
CA5B Q9Y2D0 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL28451375 1.00 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL27170285 1.00 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL3273842 1.00
Phosphoric Acid SCHEMBL734747 1.00 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL7623458 1.00
Phosphoric Acid SCHEMBL23933299 1.00 SLC34A1 (0.73) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL28704385 0.95 SLC34A1 (0.82) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL28165886 0.95
Phosphoric Acid SCHEMBL29228042 0.95 SLC34A1 (0.80) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL3947 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2366 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079360-A Method for degrading nicotine 2026-05-26 CN claimed
CN-122070479-A Ultrasonic indicating device and method for monitoring ultrasonic treatment JP实验室股份有限公司 2026-05-19 CN claimed
CN-122031770-A Bone repair material obtained by using soft-shelled turtle scale collagen as biomineralization template and preparation method thereof 武汉理工大学 2026-05-15 CN claimed
CN-122012654-A Efficient hyaluronic acid production method 新疆阜丰生物科技有限公司 2026-05-12 CN claimed
US-12622887-B2 Liquid pharmaceutical compositions comprising citrate and carnitine CASTELLANO, Giuseppe (IT) 2026-05-12 US claimed
CN-120192903-A Genetically engineered bacterium and application thereof in production of cis-3-hydroxy-L-proline 上海合全药业股份有限公司 2025-06-24 CN claimed
CN-120137842-A Universal serum-free and animal-source-free high-density fermentation medium for infectious actinobacillus pleuropneumoniae 成都史纪生物制药有限公司 2025-06-13 CN claimed
CN-120118823-A Screening preparation method and application of megalobrama amblycephala phagostimulation functional peptide FRQGDVIALP 南京农业大学 2025-06-10 CN claimed
CN-118931974-B Method for producing hydrogen by degrading non-detoxified biomass and application thereof 东莞理工学院 2025-06-03 CN claimed
CN-119954782-A Naphtho furan compound, preparation method and application of Pgp inhibitor thereof 临海市建新化工有限公司 2025-05-09 CN claimed
WO-2005079880-A1 METHODS FOR PREPARING MEDICAL IMPLANTS FROM CALCIUM PHOSPHATE CEMENT AND MEDICAL IMPLANTS CALCITEC, INC. (US) 2005-09-01 WO claimed
US-20050186353-A1 Method for making a porous calcium phosphate article CALCITEC, INC. 2005-08-25 US claimed
US-20050184417-A1 METHOD FOR MAKING A POROUS CALCIUM PHOSPHATE ARTICLE CANA LAB CORPORATION (TW) 2005-08-25 US claimed
US-20050184418-A1 Method for making a porous calcium phosphate article CALCITEC, INC. 2005-08-25 US claimed
EP-1563822-A2 Dental material based on alkoxysilyl functional polyether comprising a catalyst Kettenbach GmbH & CO. KG (DE) 2005-08-17 EP claimed
WO-2005016616-A1 METHODS FOR PREPARING MEDICAL IMPLANTS FROM CALCIUM PHOSPHATE CEMENT AND MEDICAL IMPLANTS CALCITEC, INC. (US) 2005-02-24 WO claimed
US-20050029701-A1 Method for making a molded calcium phosphate article CANA LAB CORPORATION (TW) 2005-02-10 US claimed
CN-1112915-C New scleroglucans and cosmetic compositions containing new compounds CIBA SC HOLDING AG (CH) 2003-07-02 CN claimed
EP-0891768-A2 Scleroglucans and cosmetic compositions containing them Ciba SC Holding AG (CH) 1999-01-20 EP claimed
CN-1204508-A New scleroglucans and cosmetic compositions containing new compounds CIBA SC HOLDING AG (CH) 1999-01-13 CN claimed